Sun Pharma Patent Infringements
- All
- News
-
Australia's Mayne Pharma Sues India's Sun Pharma Over Patent Infringement
Mayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said on Thursday.
-
Sun Pharma Hits Record High on Settlement of Patent Infringement Litigation
As per the terms of the settlement, Sun Pharma's subsidiary is entitled to launch its version of generic Angiomax in USA on June 30, 2019 or earlier under limited circumstances.
-
Sun Settles Angiomax Litigation With The Medicines Company
In November 2011, the company filed a patent infringement lawsuit against Sun, the release said.
-
Sun Pharma reaches settlement with Pfizer on patent lawsuit, to pay $550 mn
Pfizer Inc said Teva Pharmaceuticals Industries Ltd and Sun Pharmaceutical Industries Ltd would pay $2.15 billion to settle a patent infringement lawsuit related to its acid-reflux drug Protonix.
-
Australia's Mayne Pharma Sues India's Sun Pharma Over Patent Infringement
Mayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said on Thursday.
-
Sun Pharma Hits Record High on Settlement of Patent Infringement Litigation
As per the terms of the settlement, Sun Pharma's subsidiary is entitled to launch its version of generic Angiomax in USA on June 30, 2019 or earlier under limited circumstances.
-
Sun Settles Angiomax Litigation With The Medicines Company
In November 2011, the company filed a patent infringement lawsuit against Sun, the release said.
-
Sun Pharma reaches settlement with Pfizer on patent lawsuit, to pay $550 mn
Pfizer Inc said Teva Pharmaceuticals Industries Ltd and Sun Pharmaceutical Industries Ltd would pay $2.15 billion to settle a patent infringement lawsuit related to its acid-reflux drug Protonix.
